Home
>
National Drug Code (NDC)
>
Caverject
Caverject - 0009-5131-02 - (ALPROSTADIL)
Drug Information of Caverject
| Product NDC: | 0009-5131 |
| Proprietary Name: | Caverject |
| Non Proprietary Name: | ALPROSTADIL |
| Active Ingredient(s): | 5.4 ug/mL & nbsp; ALPROSTADIL |
| Administration Route(s): | INTRACAVERNOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Caverject
| Product NDC: | 0009-5131 |
| Labeler Name: | Pharmacia and Upjohn Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020379 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19950706 |
Package Information of Caverject
| Package NDC: | 0009-5131-02 |
| Package Description: | 6 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-5131-02) > 1 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Caverject
| NDC Code | 0009-5131-02 |
| Proprietary Name | Caverject |
| Package Description | 6 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-5131-02) > 1 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0009-5131 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ALPROSTADIL |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRACAVERNOUS |
| Start Marketing Date | 19950706 |
| Marketing Category Name | NDA |
| Labeler Name | Pharmacia and Upjohn Company |
| Substance Name | ALPROSTADIL |
| Strength Number | 5.4 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE] |
